Tom Copeman
Imperial
Research Area:
University:
Tom is a PhD in BioDesign Engineering at Imperial College London, in partnership with AstraZeneca. His passion for entrepreneurship and startups began when he worked at two Immuno-oncology startups before pursuing his PhD. Tom is interested in how synthetic biology and computational science can merge to produce groundbreaking solutions in personalised medicine.
